Mascoma Wealth Management LLC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Mascoma Wealth Management LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$61,650
+0.9%
5,0000.0%0.02%0.0%
Q2 2023$61,100
-1.5%
5,0000.0%0.02%
+5.6%
Q1 2023$62,050
+8.3%
5,0000.0%0.02%0.0%
Q4 2022$57,300
+201.6%
5,0000.0%0.02%
+157.1%
Q3 2022$19,000
-36.7%
5,0000.0%0.01%
-30.0%
Q2 2022$30,000
-6.2%
5,0000.0%0.01%0.0%
Q1 2022$32,000
+60.0%
5,0000.0%0.01%
+42.9%
Q4 2021$20,000
-16.7%
5,0000.0%0.01%
-22.2%
Q3 2021$24,000
-22.6%
5,0000.0%0.01%
-30.8%
Q1 2021$31,0005,0000.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders